Clinical Trials Browser

Nasopharyngeal Carcinoma

Colonic Neoplasms

Pathologic Complete Response, Rectal Neoplasms

Breast Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Solid Cancers

Neoplasm Metastasis, Neoplasms

Esophageal Neoplasms

Small Cell Lung Cancer Extensive Stage

Triple Negative Breast Neoplasms

Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Sarcoma, Synovial

Squamous Cell Carcinoma of Head and Neck

Neoadjuvant Therapies

Colonic Neoplasms

First-line Advanced NSCLC Patients

Carcinoma, Hepatocellular

Advanced Solid Tumors

Biliary Tract Neoplasms

Carcinoma, Non-Small-Cell Lung, Melanoma

Carcinoma, Hepatocellular

Locally Advanced Colorectal Carcinoma

Pancreatic Neoplasms

Head and Neck Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Triple Negative Breast Neoplasms

Nasopharyngeal Carcinoma, Neoplasm Metastasis, Recurrence

Carcinoma, Hepatocellular

Carcinoma, Non-Small-Cell Lung

NSCLC Stage IV Without EGFR/ALK Mutation

Lung Neoplasms

Locally Advanced Rectal Cancer (LARC)

Neoplasm Metastasis, Recurrence

Carcinoma, Non-Small-Cell Lung

Leukemia, Myeloid, Acute

Stomach Neoplasms

Advanced Solid Tumor

Esophageal Neoplasms

Nasopharyngeal Carcinoma, Neoplasm Metastasis, Recurrence

Carcinoma, Hepatocellular

Advanced NSCLC

Advanced NSCLC

Advanced NSCLC

Advanced NSCLC

Advanced Solid Tumor

Immune-related Adverse Event

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Colorectal Neoplasms

Clinical Trials

IC Plus Low-dose Radiation Plus Cadonilimab in LANPC

TRIUNITE-08

Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer（CONTROL-01）

[18F]FTT Positron Emission Tomography for the Measurement of PARP Tumor Expression in Patients With Metastatic Breast Cancer

JACKPOT38

PRISM-TNBC

MINER

iFOCUS

CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC

SKY

SBRT Combined With PD-1 Inhibitor and Chemotherapy in Early-stage TNBC

Lalo

HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma

Clinical Study of GT201 in Combination With PD-1 Inhibitor for Advanced Head and Neck Tumors

MODIFI-CC

MODIFI-L

A Phase II Study of SSGJ-706 Monotherapy and Combination Therapy in Advanced Non-Small Cell Lung Cancer（NSCLC） Patients

Multimodal Deep Learning for Postoperative Liver Cancer Risk Stratification and Intervention

Safety and Tolerability of LDRT Plus Concurrent Partial SBRT and Tislelizumab in Patients With Bulky Tumors

AT1019 Plus SBRT and PD-1 Inhibitor for Advanced Solid Tumors: An IIT Study

An Exploratory Study on the Use of Ivosidenib for the Precise Treatment of Advanced Biliary Tract Malignancies With IDH1 Mutations in the Later Line of Therapy.

USZ-STRIKE

Adjuvant PD-1 Inhibitor for Patients With Early-stage Hepatocellular Carcinoma Following Microwave Ablation

Immune Checkpoint Inhibitors + Chemotherapy Versus Chemotherapy in the Neoadjuvant Treatment of Locally Advanced Colorectal Cancer

Clinical Study of mRNA Vaccine Combined With PD-1 Inhibitor as Adjuvant Therapy for Postoperative Pancreatic Cancer

Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI

Combination Therapy for PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma: A Bayesian Adaptive Phase II Trial

TACE Combined With Lenvatinib and PD-1 Inhibitor for Ruptured Hepatocellular Carcinoma

Randomized Trial of Glutathione With Anti-PD-1 and Chemotherapy in Advanced NSCLC

A Study on Exploring the Abscopal Effect Induced by Different Radioimmunotherapy Combination Patterns in the Treatment of Non-Small Cell Lung Cancer With Multiple Metastases

Efficacy and Safety of Super-hyperfractionation Pulse Radiotherapy Combined With ICIs for Advanced NSCLC

STELLARIII

A Study of SR-8541A (ENPPI Inhibitor) in Advanced/Metastatic Solid Tumors

PROPHET

XP-005 Personalized Vaccine Alone or in Combination With Toripalimab for the Prevention of Relapse After Remission in Acute Myeloid Leukemia

A Clinical Study Evaluating the Efficacy of Systemic Chemotherapy and Immune Checkpoint Inhibitors Combined With Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Gastric Cancer Patients With Peritoneal Metastasis

Combination Therapy of Personalized mRNA-0217 Vaccines and Pembrolizumab in Patients With Advanced Solid Tumors

Postoperative Radiotherapy Followed by Immunotherapy for Locally Advanced Esophageal Carcinoma

Clinical Study of Mitoxantrone Hydrochloride Liposome Combined with PD-1 Blockade in Recurrent or Metastatic NPC

TIPS Combined With Lenvatinib and PD-1 Inhibitor for Advanced HCC With Main Trunk PVTT

Neoantigen-loaded DC Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After Second-line Treatment

Neoantigen-based Peptide Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After Second-line Treatment

Neoantigen-based Peptide Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After First-line Treatment

Neoantigen-loaded DC Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After First-line Treatment

ISCA-CHECK

The Effect of Serum Ferritin in irAE

ICI Rechallenge for Advanced NSCLC With Long-Term Response to First-Line ICI

Biomarkers in Immunotherapy of Melanoma

ATPase

ctDNA-guided Treatment of TKI Plus PD-1 Inhibitor for Advanced pMMR/MSS Colorectal Cancer